Effect of short-term administration of prostaglandin E1 on viability after ischemia/reperfusion injury with extended hepatectomy in cirrhotic rat liver

World Journal of Surgery

Volumn 27, Issue 10, 2003, Pages 1155-1160

  Hossain, Mohammad Akram ^a   Izuishi, Kunihiko ^a   Maeta, Hajime ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1; VASODILATOR AGENT;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; CELL PROTECTION; CONTROLLED STUDY; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECT; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER ISCHEMIA; LIVER RESECTION; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PORTAL VEIN BLOOD FLOW; POSTOPERATIVE PERIOD; RAT; RAT STRAIN; REPERFUSION INJURY; SURVIVAL; SURVIVAL RATE; TIME;

ALPROSTADIL; ANIMALS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; HEPATECTOMY; LIVER CIRRHOSIS; MALE; RATS; RATS, INBRED LEW; REPERFUSION INJURY; SURVIVAL RATE; TIME FACTORS; TISSUE SURVIVAL; VASODILATOR AGENTS;

EID: 0141992311     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-6914-y     Document Type: Article

References (23)

1. Une Y, Shimamura T, Uchino J. Effect of prostaglandin E1 on hepatic function after hepatectomy in patients with chronic liver disease. Clin. Ther. 1995;17:1118-1125
2. Nakadaira K, Tsukada K, Sakaguchi T, et al. A pharmacological analysis of prostaglandin E1 on portal blood flow after partial hepatectomy in rats. Surg. Today 1993;23:277-279
3. Nabeshima M, Moriyasu F, Nishikawa K, et al. Evaluation of protective effects of prostaglandin E1 on ischemic liver damage with in vivo 31P-MR. Magn. Reson. Med. 1995;34:457-461
4. Helling TS, Wogahn BM, Olson SA, et al. The effect of prostaglandin E1 on liver adenine nucleotides and cytoplasmic enzymes in a porcine model of normothermic hepatic ischemia. Hepatology 1995;22:1554-1559
5. Aono T, Sakaguchi T, Tsukada K, et al. Effect of prostaglandin E1 on ammonia concentration in blood of patients with hepatic resection. Dig. Dis. Sci. 1995;41:126-130
6. Endoh Y, Motoki R, Inoue H, et al. Effects of prostaglandin E1 on the function of organs in patients after hepatectomy. World J. Surg. 1994; 18:S36
7. Isai H, Sheil AGR, McCaughan G, et al. Successful reversal of primary graft non-function in a liver transplant patient treated with prostaglandin E1. Aust. N.Z. Surg. 1992;62:314-316
8. Kawachi S, Shimazu M, Wakabayashi G, et al. Efficacy of intraportal infusion of prostaglandin E1 to improve the hepatic blood flow and graft viability in porcine liver transplantation. Transplantation 1997;64: 205-209
9. Hossain MA, Hamamoto I, Wakabayashi H, et al. Experimental study of intraportal prostaglandin E1 on hepatic blood flow during reperfusion following ischemia and partial hepatectomy. Br. J. Surg. 1999;86: 776-783
10. Sinclair S, Levy G. Eicosanoids and the liver. Ital. J. Gastroenterol. 1990;22:205-213
11. Kurokawa T, Nonami T, Harada A, et al. Effects of prostaglandin E1 on the recovery of ischemia-induced liver mitochondrial dysfunction in rats with cirrhosis. Scand. J. Gastroenterol. 1991;26:269-274
12. Matsumoto H, Hirose H, Senga S, et al. Influence of intermittent ischemia on thioacetamide-induced rat liver cirrhosis. Eur. Surg. Res. 1998;30:185-190
13. Hanazaki K, Kajikawa S, Fujimori Y, et al. Effects of prostaglandin E1 administration during hepatectomy for cirrhotic hepatocellular carcinoma. Hepatogastroenterology. 2000;47:461-464
14. Sugawara Y, Kubota K, Ogura T, et al. Protective effect of prostaglandin E1 against ischemia/reperfusion-induced liver injury: results of a prospective, randomized study in cirrhotic patients undergoing subsegmentectomy. J. Hepatol. 1998;29:969-976
15. Hamamoto I, Hossain MA, Mori S, et al. Impact of adhesion molecules of the selectin family on liver microcirculation at reperfusion following cold ischemia. Transpl. Int. 1996;9:454-460
16. Pringle JH. Notes on the arrest of hepatic hemorrhage due to trauma. Ann. Surg. 1908;48:541-549
17. Totsuka E, Sasaki M, Takahashi K, et al. The effects of intraportal prostaglandin E1 administration on hepatic warm ischemia and reperfusion injury in dogs. Surg. Today 1995;25:421-428
18. Tsukada K, Katoh H, Iga Y, et al. Prostaglandin E1 enhances hepatic portal venous flow by dilating the portal vascular bed in 70% hepatectomized dog. Gastroenterol. Jpn. 1992;27:341-347
19. Fabbri A, Bianchi G, Brizi M, et al. Effects of systemic prostaglandin E on hepatic amino acid-nitrogen metabolism in patients with cirrhosis. Hepatology 1998;27:815-821
20. Shinohara H, Tanaka A, Fujimoto T, et al. Prostaglandin E1 resuscitates hepatic organic anion transport independent of its hemodynamic effect after warm ischemia. J. Surg. Res. 1997;68:56-62
21. Yoshikawa T, Oyamada H, Ichikawa H, et al. Role of active oxygen species and lipid peroxidation in liver injury induced by ischemia-reperfusion. Jpn. J. Gastroenterol. 1990;87:199-205
22. Ishida T. The experimental study of PGE1 infusion on the liver circulation. Nippon Geka Gakkai Zasshi. 1988;89:898-905
23. Natori S, Fuji Y, Kurosawa H, et al. Prostaglandin E1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells. Transplantation 1997;64:1514-1520